XNCRXencor Incvs its industry peers
A metric-by-metric comparison of Xencor Inc against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XNCREsta | $1.8B#8 | — | 3.6x#7 | 14.6x#6 | 13.7%#11 | 60.5%#5 | -141.4%#8 | -18.3%#8 | -31.5%#5 | — | 165.0%#4 | — |
| ZBIO | $2.1B#1 | — | 8.4x#11 | 208.5x#11 | 100.0%#6 | -140.6%#12 | -3830.6%#12 | -152.9%#15 | -296.6%#6 | — | 67.4%#7 | — |
| RAPP | $2.0B#2 | — | 4.8x#8 | — | — | -42.4%#10 | — | -26.4%#9 | — | — | 59.5%#8 | — |
| AGIO | $2.0B#3 | — | 2.0x#4 | 37.1x#9 | 48.0%#7 | -161.3%#13 | -873.9%#11 | -40.3%#11 | — | — | -7.7%#12 | — |
| ZYME | $2.0B#4 | — | 24.3x#12 | 18.4x#7 | 38.9%#9 | 33.9%#6 | -87.3%#7 | -100.9%#13 | — | — | 72.9%#6 | — |
| PRGO | $1.9B#5 | — | 0.7x#1 | 0.4x#1 | -2.8%#12 | -729.7%#14 | -26.4%#6 | -56.7%#12 | -20.9%#4 | 4#2 | -30.7%#14 | 8.5%#1 |
| STOK | $1.9B#6 | — | 5.4x#10 | 10.1x#5 | 404.5%#3 | 92.3%#3 | -11.2%#5 | -2.0%#5 | — | — | 27.2%#9 | — |
| SEPN | $1.8B#7 | — | 4.8x#9 | 40.1x#10 | 4174.5%#1 | 31.9%#7 | -148.6%#9 | -12.6%#7 | — | — | 174.3%#3 | — |
| ANIP | — | 16.4x#2 | — | — | 43.8%#8 | 510.5%#2 | 12.6%#3 | 13.1%#2 | 16.9%#1 | — | -21.0%#13 | — |
| KLRA | $1.7B#9 | — | 1.5x#3 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ETON | $1.6B#10 | — | 35.0x#13 | 20.4x#8 | 104.9%#5 | -20.4%#9 | -1.1%#4 | -9.9%#6 | -1.8%#3 | 4#2 | 224.3%#1 | — |
| ANAB | $1.6B#11 | — | 125.5x#15 | 6.8x#3 | 157.0%#4 | 90.9%#4 | 20.4%#2 | -103.8%#14 | — | — | 178.2%#2 | — |
| SNDX | $1.6B#12 | — | 104.5x#14 | 9.2x#4 | 627.8%#2 | 10.5%#8 | -158.4%#10 | -1890.2%#16 | -1205.8%#7 | — | 19.8%#10 | — |
| KARD | $1.6B#13 | — | 2.5x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| INVA | $1.5B#14 | 4.9x#1 | 1.2x#2 | 3.7x#2 | 14.7%#10 | 1059.2%#1 | 39.8%#1 | 22.0%#1 | 14.7%#2 | 5#1 | 8.8%#11 | — |
| BCAX | $1.5B#15 | — | 3.2x#6 | — | — | -102.9%#11 | — | -29.4%#10 | — | — | 106.2%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice